Cargando…
COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation
The year 2020 will be carved in the history books—with the proliferation of COVID-19 over the globe and with frontline health workers and basic scientists worldwide diligently fighting to alleviate life-threatening symptoms and curb the spread of the disease. Behind the shocking prevalence of death...
Autores principales: | Yu, Jihang, Azzam, Edouard I., Jadhav, Ashok B., Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470324/ https://www.ncbi.nlm.nih.gov/pubmed/34571861 http://dx.doi.org/10.3390/cells10092212 |
Ejemplares similares
-
Immunological and hematological outcomes following protracted low dose/low dose rate ionizing radiation and simulated microgravity
por: Paul, Amber M., et al.
Publicado: (2021) -
Low-dose ionizing radiation — is it harmful to health?
Publicado: (1987) -
Application of Low Doses of Ionizing Radiation in Medical Therapies
por: Cuttler, Jerry M.
Publicado: (2020) -
Low dose ionizing radiation effects on the immune system
por: Lumniczky, Katalin, et al.
Publicado: (2021) -
Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation
por: Colangelo, Nicholas W., et al.
Publicado: (2020)